Publications by authors named "Stuart Spencer"

Claim this Profile
R
Rapid, accurate publication and dissemination of clinical trial results: benefits and challenges.
Faiez Zannad, Filippo Crea, John Keaney, Stuart Spencer, Joseph A Hill

Eur Heart J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonsurgical management of adenomyosis: an overview of current evidence.
Alexandros Lazaridis, Alexandros L Grammatis, Stuart Spencer, Martin Hirsch

Curr Opin Obstet Gynecol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The treatment of endometriosis-associated infertility.
Stuart Spencer, Alexandros Lazaridis, Alexandros Grammatis, Martin Hirsch

Curr Opin Obstet Gynecol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
Yuanbin Chen, Luis Paz-Ares, Niels Reinmuth, Marina Chiara Garassino, Galina Statsenko, Stuart Spencer

JTO Clin Res Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiology and big data: a call for papers.
Stuart Spencer, Rupa Sarkar

Lancet Digit Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiology and big data: a call for papers.
Stuart Spencer, Rupa Sarkar

Lancet· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early predictions of response and survival from a tumor dynamics model in patients with recurrent, metastatic head and neck squamous cell carcinoma treated with immunotherapy.
Ignacio González-García, Vadryn Pierre, Vincent F S Dubois, Nassim Morsli, Stuart Spencer

CPT Pharmacometrics Syst Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ergometrine for postpartum hemorrhage and associated myocardial ischemia: Two case reports and a review of the literature.
Stuart P E Spencer, Sandra A Lowe

Clin Case Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Effects and Safety of Olaparib Administered with Endocrine Therapy: A Phase I Study in Patients with Advanced Solid Tumours.
Ruth Plummer, Henk M Verheul, Filip Y F L De Vos, Karin Leunen, L Rhoda Molife, Stuart Spencer

Adv Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
Darren R Hodgson, Brian A Dougherty, Zhongwu Lai, Anitra Fielding, Lynda Grinsted, Stuart Spencer

Br J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Michael Friedlander, Ursula Matulonis, Charlie Gourley, Andreas du Bois, Ignace Vergote, Stuart Spencer

Br J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Success for the National Research School in General Medicine].
Simon Griffin, Lars Lindholm, Stuart Spencer

Lakartidningen· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Brian A Dougherty, Zhongwu Lai, Darren R Hodgson, Maria C M Orr, Matthew Hawryluk, Stuart K Spencer

Oncotarget· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data Science Solution to Event Prediction in Outsourced Clinical Trial Models.
Daniel Dalevi, Susan Lovick, Helen Mann, Paul D Metcalfe, Stuart Spencer

Stud Health Technol Inform· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Stuart Spencer

Lancet Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer.
Jonathan A Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Stuart Spencer

Br J Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Ursula A Matulonis, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Stuart Spencer

Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A global perspective on hypertension: a Lancet Commission.
Michael Hecht Olsen, Stuart Spencer

Lancet· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from the PURE study.
Stuart Spencer

Glob Cardiol Sci Pract· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Stuart Spencer

Lancet Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[National research school has a global reach. Graduate students reaches far both scientifically and geographically].
Lars H Lindholm, Stuart Spencer

Lakartidningen· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Burden of Disease 2010 Study: A personal reflection.
Stuart Spencer

Glob Cardiol Sci Pract· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of lactate dehydrogenase isoenzyme profile with outcome in patients with advanced colorectal cancer treated with chemotherapy and bevacizumab or cediranib: Retrospective analysis of the HORIZON I study.
Jair Bar, Stuart Spencer, Shethah Morgan, Laura Brooks, David Cunningham

Clin Colorectal Cancer· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
Caroline Robert, Reinhard Dummer, Ralf Gutzmer, Paul Lorigan, Kevin B Kim, Stuart Spencer

Lancet Oncol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thailand glimpses success.
Stephanie Clark, Stuart Spencer

Lancet· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis